Immunotherapy-related acute kidney injury: Kidney biopsy or not?

Nephrology (Carlton). 2021 Jan;26(1):89-90. doi: 10.1111/nep.13687. Epub 2020 Jan 12.

Authors

Sophie Chatterton¹, Sarah Williams¹, Kazi Nahar^{1

2}, Alexander M Menzies^{1

2

3}, Muh G Wong^{1

4}

Affiliations

¹ Oncology and Renal Departments, Royal North Shore Hospital, Sydney, New South Wales, Australia.
² Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia.
³ Oncology Department, Mater Hospital, Sydney, New South Wales, Australia.
⁴ The George Institute for Global Health, Sydney, New South Wales, Australia.

PMID: 31930649
DOI: 10.1111/nep.13687

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acute Kidney Injury / chemically induced*
Acute Kidney Injury / pathology*
Acute Kidney Injury / therapy
Antineoplastic Agents, Immunological / administration & dosage
Antineoplastic Agents, Immunological / adverse effects*
Biopsy*
Humans
Ipilimumab / administration & dosage
Ipilimumab / adverse effects*
Male
Middle Aged
Nivolumab / administration & dosage
Nivolumab / adverse effects*
Patient Selection

Substances

Antineoplastic Agents, Immunological
Ipilimumab
Nivolumab